Severe Isolated Thrombocytopenia in a 33-Week Infant With Petechiae
At 33+6 weeks, a 2,100-g female is born vaginally to a mother whose platelet count is 210,000/µL. At 6 hours, the infant has petechiae over the chest and a small bruise at a heel-stick site, but no active bleeding. Platelet count is 14,000/µL; WBC 12,000/µL; hemoglobin 15 g/dL; CRP 4 mg/L; blood culture is pending. The infant is feeding well, has normal tone, and has no hepatosplenomegaly, microcephaly, or rash. Head ultrasound is normal. The mother has no history of immune thrombocytopenia, but a maternal aunt has a child with a bleeding disorder. The NICU has random-donor platelets available; HPA-1a-negative platelets would take 24 hours to obtain; IVIG is available. The team is debating whether to give intramuscular vitamin K.
1. What is the most likely diagnosis, and what is the immediate danger?
Read the worked answer
The most likely diagnosis is neonatal alloimmune thrombocytopenia. The infant has isolated severe thrombocytopenia at 14,000/µL, petechiae, a well-appearing examination, a normal maternal platelet count, and no signs of congenital infection. Sepsis can cause thrombocytopenia, but the infant is feeding well and the CRP is only 4 mg/L; blood culture is pending. Congenital infections such as CMV or toxoplasmosis usually have hepatosplenomegaly, growth restriction, or other findings. The immediate danger is intracranial hemorrhage, which can occur even without neurologic signs and is most likely in the first days. A normal head ultrasound does not exclude a small hemorrhage. Avoid intramuscular injections, including vitamin K, until the platelet count is safer; give vitamin K intravenously or subcutaneously.
2. Do you transfuse platelets, and which product? Explain the threshold and alternatives.
Read the worked answer
Transfuse platelets urgently because the count is 14,000/µL with petechiae, well below the usual threshold of 20,000–30,000/µL. HPA-1a-negative platelets are preferred, but waiting 24 hours is unsafe when severe thrombocytopenia and bleeding risk are present. Give random-donor platelets now; they may be less effective but can raise the count and reduce hemorrhage risk while compatible platelets are arranged. Recheck the platelet count after transfusion. Give IVIG 1 g/kg as adjunctive therapy; it can raise the platelet count over 24–48 hours by blocking maternal antibody. Do not delay transfusion for HPA typing or paternal testing. If there is active bleeding or a fall in hemoglobin, escalate to repeated platelet transfusions and urgent neuroimaging.
3. What monitoring and family counseling are needed, including implications for future pregnancies?
Read the worked answer
Monitor for bleeding, especially intracranial hemorrhage: check tone, feeding, seizures, and head circumference, and repeat head ultrasound if neurologic signs appear. Avoid NSAIDs, aspirin, and intramuscular injections; use gentle handling and pressure on puncture sites. Counsel the family that NAIT is caused by maternal antibodies against fetal platelet antigens, not by anything the mother did, and that it can recur in future pregnancies. The recurrence risk is high if the father carries the same antigen, so future pregnancies need early specialist planning with maternal IVIG and fetal monitoring. Explain that the current platelet count should improve over days to weeks, but follow-up with a pediatric hematologist is needed. Delay circumcision until the platelet count is safe. Document the antigen status once available.